Arbor Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$230K Buy
+3,694
New +$217K 0.05% 58
2019
Q3
Sell
-930
Closed -$42K 68
2019
Q2
$42K Hold
930
0.02% 91
2019
Q1
$44K Buy
+930
New +$46.3K 0.03% 84
2018
Q1
Sell
-4,357
Closed -$266K 60
2017
Q4
$266K Buy
+4,357
New +$273K 0.2% 60
2016
Q3
Sell
-12,629
Closed -$962K 74
2016
Q2
$962K Hold
12,629
0.91% 35
2016
Q1
$897K Buy
12,629
+126
+1% +$7.95K 0.93% 32
2015
Q4
$756K Buy
+12,503
New +$826K 0.83% 33

Other funds holding BMY

Arbor Wealth Management's BMY Position: Q4 2021 in Review

Arbor Wealth Management opened a new position in Bristol-Myers Squibb (BMY) in Q4 2021: 3,694 shares worth $230K. The stake represents 0.05% of the portfolio and ranks #58 among its holdings. This is a return to the name: Arbor Wealth Management previously reported a position in BMY as recently as Q2 2019.

Arbor Wealth Management first reported a position in BMY in Q4 2015 and has held it in 7 quarters since. The position peaked at $962K in Q2 2016. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • Arbor Wealth Management held 3,694 shares of Bristol-Myers Squibb worth $230K as of Q4 2021.
  • Bristol-Myers Squibb was a new Arbor Wealth Management position in Q4 2021.
  • Bristol-Myers Squibb made up 0.05% of Arbor Wealth Management's portfolio in Q4 2021, its #58 holding.
  • Arbor Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 7 quarters since.
  • Arbor Wealth Management's Bristol-Myers Squibb position peaked at $962K in Q2 2016.
  • 2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Arbor Wealth Management's 13F filing for Q4 2021, filed 25 Jan 2022.